top of page


Ancre PascalM

Pascale Massin

Principales publications depuis 2014


•   Quellec G, Lamard M, Erginay A, Chabouis A, Massin P, Cochener B, Cazuguel G. Automatic detection of referral 

    patients due to retinal pathologies through data mining. Med Image Anal. 2016 Apr;29:47-64.


•   Philippakis E, Couturier A, Gaucher D, Gualino V, Massin P, Gaudric A,Tadayoni R. posterior vitreous detachment

    in highly myopic eyes undergoing vitrectomy. retina. 2015 dec 13.


•   Guillard M, Dupas B, El Sanharawi M, Erginay A, Tadayoni R, Massin P. Symmetry in early response to

    intravitreal ranibizumab in bilateral diabetic macular oedema. Acta Ophthalmol. 2015 Nov 13.


•   Couturier A, Mané V, Bonnin S, Erginay A, Massin P, Gaudric A, Tadayoni R. Capillary Plexus Anomalies In

     Diabetic Retinopathy On Optical Coherence Tomography Angiography. Retina. 2015 Nov;35(11):2384-91.


•   Yang Y, Bailey C, Loewenstein A, Massin P. Intravitreal corticosteroids indiabetic macular edema:

     Pharmacokinetic Considerations. Retina. 2015 Dec;35(12):2440-9.


•   Mitchell P, Massin P, Bressler S, Coon CD, Petrillo J, Ferreira A, BresslerNM. Three-year patient-reported

     visual function outcomes in diabetic macular edema managed with ranibizumab: the RESTORE extension study.

     Curr Med Res Opin.2015 Nov;31(11):1967-75.


•   Ribeiro L, Bandello F, Tejerina AN, Vujosevic S, Varano M, Egan C, Sivaprasad S, Menon G, Massin P,

     Verbraak FD, Lund-Andersen H, Martinez JP, Jürgens I, Smets E, Coriat C, Wiedemann P, Ágoas V, Querques G,

     Holz FG, Nunes S, Neves C,Cunha-Vaz J; Evicr Net Study Group. Characterization of Retinal Disease Progression in

     a 1-Year Longitudinal Study of Eyes With MildNonproliferative Retinopathy in Diabetes Type 2. Invest Ophthalmol

     Vis Sci. 2015 Aug;56(9):5698-705.


•   Bandello F, Tejerina AN, Vujosevic S, Varano M, Egan C, Sivaprasad S, Menon G,Massin P, Verbraak FD,

     Lund-Andersen H, Martinez JP, Jürgens I, Smets RM, Coriat C, Wiedemann P, Ágoas V, Querques G, Holz FG,

     Nunes S, Alves D, Neves C, SantosT, Ribeiro L, Cunha-Vaz J; Retinal layer location of increased

     retinal thickness in eyes with subclinical and clinical macular edema in diabetes type 2. Ophthalmic Res.



•   Bonnin S, Dupas B, Sanharawi ME, Perol J, Erginay A, Tadayoni R, Massin P.Efficacy of dexamethasone

     intravitreal implant for the treatment of diabetic macular edema. Eur J Ophthalmol. 2015 Sep-Oct;25(5):448-53.


•   Bellocq D, Korobelnik JF, Burillon C, Voirin N, Dot C, Souied E, Conrath J, Milazzo S, Massin P, Baillif S, Kodjikian L.

     Effectiveness and safety of dexamethasone implants for post-surgical macular oedema including Irvine-Gass

     syndrome: the EPISODIC study. Br J Ophthalmol. 2015 Jul;99(7):979-83.


•   Bonnin S, Tadayoni R, Erginay A, Massin P, Dupas B. Correlation between ganglion cell layer thinning and poor

     visual function after resolution of diabetic macular edema. Invest Ophthalmol Vis Sci. 2015 Jan 8;56(2):978-82.


•   Jacob J, Paques M, Krivosic V, Dupas B, Couturier A, Kulcsar C, Tadayoni R,Massin P, Gaudric A. Meaning of

     visualizing retinal cone mosaic on adaptive optics images. Am J Ophthalmol. 2015 Jan;159(1):118-23.e1.


•   Massin P, Peto T, Ansquer JC, Aubonnet P, MacuFEN Study Investigators FT. Effects of fenofibric acid on diabetic

     macular edema: the MacuFen study. Ophthalmic Epidemiol. 2014 Oct;21(5):307-17.


•   Dupas B, Feldman-Billard S, Bui Quoc E, Erginay A, Guillausseau PJ, Massin P.Influence of pulse pressure and

     spontaneous variations of macular thickness in patients with diabetic macular oedema. Acta Ophthalmol. 2014



•   Krivosic V, Massin P, Desjardins L, Le Hoang P, Tadayoni R, Gaudric A. Management of idiopathic retinal

     vasoproliferative tumors by slit-lamp laser or endolaser photocoagulation. Am J Ophthalmol.

     2014 Jul;158(1):154-161.e1.


•   Boyer DS, Yoon YH, Belfort R Jr, Bandello F, Maturi RK, Augustin AJ, Li XY,Cui H, Hashad Y, Whitcup SM;

     Ozurdex MEADStudy Group. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal

     implant in patients with diabetic macular edema. Ophthalmology. 2014 Oct;121(10):1904-14.


•   Zhang X, Thibault G, Decencière E, Marcotegui B, Laÿ B, Danno R, Cazuguel G, Quellec G, Lamard M, Massin P,

    Chabouis A, Victor Z, Erginay A. Exudate detection in color retinal images for mass screening of diabetic retinopathy.

    Med ImageAnal. 2014 Oct;18(7):1026-43.


•   Couturier A, Dupas B, Guyomard JL, Massin P. Surgical outcomes of florid diabetic retinopathy treated with

     antivascular endothelial growth factor. Retina.2014 Oct;34(10):1952-9.


•   Bonnin P, Pournaras JA, Makowiecka K, Krivosic V, Kedra AW, Le Gargasson JF, Gaudric A, Levy BI,

     Cohen YS, Tadayoni R, Massin P. Ultrasound assessment of ocular vascular effects of repeated intravitreal

     injections of ranibizumab for wet age-related macular degeneration. Acta Ophthalmol.

     2014 Aug;92(5):e382-7.


•   Schmidt-Erfurth U, Lang GE, Holz FG, Schlingemann RO, Lanzetta P, Massin P,Gerstner O, Bouazza AS, Shen H,

    Osborn A, Mitchell P; RESTORE Extension StudyGroup. Three-year outcomes of individualized ranibizumab

    treatment in patientswith diabetic macular edema: the RESTORE extension study. Ophthalmology.

    2014 May;121(5):1045-53.

bottom of page